News tagged with inferiority
Neuroscientists find Broca's area is really two subunits, each with its own function
A century and a half ago, French physician Pierre Paul Broca found that patients with damage to part of the brain's frontal lobe were unable to speak more than a few words. Later dubbed Broca's area, this ...
Neuroscience
Oct 16, 2012 |
3.8 / 5 (5) |
1
|
Distinct brain cells recognize novel sights
No matter what novel objects we come to behold, our brains effortlessly take us from an initial "What's that?" to "Oh, that old thing" after a few casual encounters. In research that helps shed light on the ...
Neuroscience
Apr 11, 2012 |
not rated yet |
0
|
Reducing academic pressure may help children succeed
Children may perform better in school and feel more confident about themselves if they are told that failure is a normal part of learning, rather than being pressured to succeed at all costs, according to new research published ...
Psychology & Psychiatry
Mar 12, 2012 |
4 / 5 (4) |
0
|
Rivaroxaban found noninferior to enoxaparin in acutely ill
(HealthDay)—In acutely ill hospitalized patients, standard-duration rivaroxaban has similar efficacy as enoxaparin in reducing the risk of venous thromboembolism, while extended-duration rivaroxaban has ...
Diseases, Conditions, Syndromes
Feb 07, 2013 |
not rated yet |
0
Insulin LY2605541 tops glargine for glycemic control in T1DM
(HealthDay)—For patients with type 1 diabetes, the novel, long-acting basal insulin LY2605541 yields greater improvement in glycemic control compared with insulin glargine, according to a study published ...
Diabetes
Jan 13, 2013 |
5 / 5 (1) |
0
Neuroscience reveals brain differences between Republicans and Democrats
With the U.S. presidential election just days away, new research from the University of South Carolina provides fresh evidence that choosing a candidate may depend more on our biological make-up than a careful analysis of ...
Neuroscience
Nov 01, 2012 |
3 / 5 (2) |
9
Brain connectivity altered in type 2 diabetes
(HealthDay) -- Patients with type 2 diabetes mellitus (T2DM) have reduced functional connectivity in the default mode network, which is associated with insulin resistance in some brain regions, according to ...
Diabetes
Aug 01, 2012 |
not rated yet |
0
Trials involving switching HIV drugs may not be beneficial to participants
A increasingly used type of HIV study which involves switching patients on one type of antiretroviral therapy (ART) to another, to see whether the new drug is as good as the at preventing replication of the HIV virus, may ...
HIV & AIDS
Jul 17, 2012 |
not rated yet |
0
Atrial fibrillation: Flec-SL trial proves efficacy of short-term antiarrhythmic drug treatment
Atrial fibrillation (AF) is the most frequently sustained arrhythmia of the heart. It affects several million people in Europe. AF causes a loss of contraction in the atria and gives rise to heart failure. Moreover, it is ...
Cardiology
Jun 18, 2012 |
not rated yet |
0
Biodegradable stent proves non-inferior to drug-eluting stent
The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...
Cardiology
May 21, 2013 |
5 / 5 (1) |
0
Results of the EVOLVE trial reported at TCT 2011
A clinical trial has established the non-inferiority of a drug-eluting stent with a bioabsorbable polymer compared to a drug-eluting stent with a durable polymer. Results of the EVOLVE clinical trial were presented today ...
Cardiology
Nov 11, 2011 |
not rated yet |
0
Clinical outcomes in PCI patients given sirolimus-eluting and everolimus-eluting stents
The second generation drug-eluting stent, everolimus-eluting stent (EES), has consistently demonstrated superior clinical outcomes in randomised controlled trials over the first generation drug-eluting stent, paclitaxel-eluting ...
Cardiology
Aug 29, 2011 |
not rated yet |
0
